Université Bordeaux Segalen;Centre Hospitalier Universitaire de Bordeaux
发明人:
LÉAUTÉ-LABRÉZE, CHRISTINE,DUMAS DE LA ROCHE, ÉRIC,TAIEB, ALAIN,THAMBO, JEAN-BENOIT,LEAUTE-LABREZE CHRISTINE,LÉAUTÉ-LABRÉZE CHRISTINE,DUMAS DE LA ROCHE ERIC,DUMAS DE LA ROCHE ÉRIC,TAIEB ALAIN,THAMBO JEAN-BENOIT
申请号：
PL09015563
公开号：
PL2233135T3
申请日:
2008.10.16
申请国别(地区):
PL
年份:
2012
代理人:
摘要：
The present invention relates the use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas, for example of infantile hemangiomas. The beta blocker may be a non-selective beta-blocker, for example propranolol. The present invention provides an alternative to the known compounds, e.g. coroticosteroïds, interferon or vincristine, generally used for the treatment of hemangiomas.
